Table 2.
Treatment overview
Treatment features | Number (n) | Percentage (%) | |
---|---|---|---|
Operation status | operation indicated | 307 | 41.5 |
no operation indicated | 418 | 56.6 | |
patient rejected operation | 14 | 1.9 | |
Treatment modality | definitive RT | 247 | 33.4 |
CCRT | 181 | 24.5 | |
preop-RT | 3 | 0.4 | |
postop-RT | 240 | 32.5 | |
postop-CCRT | 37 | 5.0 | |
only ICRT | 1 | 0.1 | |
palliative RT | 2 | 0.3 | |
no treatment | 28 | 3.8 | |
External RT time | average | 38 days | |
range | 15–104 days | ||
< 45 days | 622 | 84.2 | |
45–60 days | 67 | 9.1 | |
61–80 days | 14 | 1.9 | |
> 80 days | 7 | 0.9 | |
Definitive RT dose | average | 50 Gy | |
range | 45–70 Gy | ||
Postop-RT dose | average | 50 Gy | |
range | 45–62 Gy | ||
ICRT | absent | 573 | 77.5 |
present | 166 | 22.5 | |
ICRT dose | median | 24 Gy | |
range | 8–35 Gy | ||
Para-aortic field RT | absent | 728 | 98.5 |
present | 11 | 1.5 | |
Parametrial boost | absent | 666 | 90.2 |
present | 73 | 9.8 | |
Parametrial boost dose | median | 10 Gy | |
range | 4–20 Gy |
RT – radiation therapy; CCRT – concurrent chemotherapy; ICRT – intracavitary radiotherapy